Outcomes are reported from an electronic cardiovascular disease (CVD) risk assessment programme conducted over 12 months (between December 2006 and November 2007) at Tāmaki Healthcare, Auckland. Of 1522 people screened, clinical data were available for 1420, 425 (30.0%) of whom had a clinical or calculated 5-year CVD risk of ≥15%. Māori were significantly more likely to be at high CVD risk than non-Māori (OR, 2.07; p≤0.001). Despite high smoking rates and diabetes among Pacific peoples, there was not an overall increased likelihood of high CVD risk. For people at high CVD risk, across all ethnicities, prescribing rates were 78.1% for blood pressure lowering, 71.9% for lipid lowering, 65.3% for antiplatelet, and 50.3% for all three therapies. Of 451 people with either diabetes or established CVD, 65.9% and 66.1% were not attaining target blood pressure and lipid level recommendations respectively or were not prescribed guideline indicated therapies.
